To facilitate the identification and treatment of breast cancer, the medical community has classified breast cancer into luminal A, luminal B, human epidermal growth factor receptor (HER2) positive, and triple-negative breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.